Humanetics Corporation Revenue and Competitors

Location

$9.2M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Humanetics Corporation's estimated annual revenue is currently $1.8M per year.(i)
  • Humanetics Corporation's estimated revenue per employee is $100,500
  • Humanetics Corporation's total funding is $9.2M.

Employee Data

  • Humanetics Corporation has 18 Employees.(i)
  • Humanetics Corporation grew their employee count by 50% last year.

Humanetics Corporation's People

NameTitleEmail/Phone
1
CEO and member the Board DirectorsReveal Email/Phone
2
Chief Medical OfficerReveal Email/Phone
3
VP Research and DevelopmentReveal Email/Phone
4
Chief Operating OfficerReveal Email/Phone
5
Chief Medical OfficerReveal Email/Phone
6
Director CMCReveal Email/Phone
7
Program Manager - Oncology and Medical CountermeasuresReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.9M69-13%N/AN/A
#2
$110.3M549-3%N/AN/A
#3
$14.1M701%N/AN/A
#4
$1051.4M5231-5%N/AN/A
#5
$55.9M27822%N/AN/A
#6
$50.3M250N/AN/AN/A
#7
$2.2M22214%N/AN/A
#8
$1.4M7-87%N/AN/A
#9
$68.1M33917%N/AN/A
#10
$19.5M970%N/AN/A
Add Company

What Is Humanetics Corporation?

Humanetics is a new breed of specialty pharmaceutical company focused on discovery, development and commercialization of proprietary, orally-administered, bioactive compounds for disease prevention. The Company has an extensive patent portfolio and an active pipeline of compounds that range from discovery phase to human clinical trials. The company is focused on three large biotherapeutic areas with urgent and unmet needs including immunodeficiency disorders, neurodegenerative diseases and metabolic dysfunction. Current disease targets within these biotherapeutic areas include Acute Radiation Syndrome (ARS), antibiotic resistant bacteria, Alzheimer’s disease, obesity and cardiovascular disease.

keywords:N/A

$9.2M

Total Funding

18

Number of Employees

$1.8M

Revenue (est)

50%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Humanetics Corporation News

2022-04-20 - New Studies Published Comparing BIO 300 to Neulasta® for ...

... studies conducted with Humanetics Corporation's (Humanetics) new ... Humanetics compared the efficacy of BIO 300 to that of Neulasta®,...

2022-04-17 - Joint Health Ingredients Market Size, Outlook And Forecast ...

P&G, Humanetics Corporation, Keratec Ltd., DuPont, Archer Daniels Midland Company, BASF SE, PL Thomas, Soft Gel Technologies, TSI Health...

2022-04-06 - Mr. Douglas W. Bryce, Former Joint Program Executive Officer ...

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in the discovery, development, and commercialization of proprietary...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M18-10%N/A
#2
$2.7M180%N/A
#3
$1.7M1958%N/A
#4
$1.7M196%N/A
#5
$1.7M20-13%N/A